Fed. Circ. Upholds Dana-Farber's IP Inventorship Victory

Law360 (July 14, 2020, 10:41 PM EDT) -- The Federal Circuit on Tuesday affirmed that a pair of American scientists should be named as co-inventors on six patents involved in Nobel Prize-winning cancer research, finding Ono Pharmaceutical was trying to push "an unnecessarily heightened inventorship standard."

In a victory for the Dana-Farber Cancer Institute, the Federal Circuit panel unanimously concluded that Gordon Freeman and Clive Wood should be named alongside Japanese researchers as co-inventors. The precedential opinion concludes that they made significant contributions toward discovering the existence of a protein that later spawned a new cancer treatment.

"Dana-Farber is very pleased with the Federal Circuit's unanimous affirmance in this...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!